Intrust Bank Na Catalent, Inc. Transaction History

Intrust Bank Na

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$45.44 - $74.26 $174,535 - $285,232	3,841 New	3,841 $252,000
Q2 2022 Aug 16, 2022	BUY	$87.2 - $114.05 $55,633 - $72,763	638 Added 26.5%	3,046 $327,000
Q1 2022 May 10, 2022	BUY	$94.19 - $124.49 $17,801 - $23,528	189 Added 8.52%	2,408 $267,000
Q4 2021 Feb 03, 2022	SELL	$119.57 - $139.07 $2,989 - $3,476	-25 Reduced 1.11%	2,219 $284,000
Q3 2021 Nov 04, 2021	BUY	$109.17 - $142.35 $8,187 - $10,676	75 Added 3.46%	2,244 $299,000
Q2 2021 Aug 05, 2021	BUY	$100.34 - $115.69 $10,736 - $12,378	107 Added 5.19%	2,169 $235,000
Q1 2021 Jun 02, 2021	BUY	$101.51 - $125.27 $2,740 - $3,382	27 Added 1.33%	2,062 $217,000
Q4 2020 Feb 10, 2021	BUY	$85.88 - $105.36 $174,765 - $214,407	2,035 New	2,035 $212,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Intrust Bank Na, based on Form 13F filings with the SEC.

Stay updated on Intrust Bank Na with notifications on news.